tradingkey.logo
搜尋

OptimizeRx Corp

OPRX
添加自選
6.190USD
+0.110+1.81%
收盤 07/02, 13:00美東報價延遲15分鐘
116.16M總市值
16.76本益比TTM

OptimizeRx Corp

6.190
+0.110+1.81%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.81%

5天

+26.33%

1月

+17.23%

6月

-50.16%

今年開始到現在

-49.51%

1年

-52.82%

關鍵數據
6.140今開
6.500最高
519.64K成交量
16.76本益比TTM
5.48本益比動
--股利TTM
2.77%換手率
6.080昨收
6.040最低
2.72M成交額
虧損本益比靜
0.90市淨率
0.00%股息率 TTM
4.08%ROA
22.25052週最高
1.24量比
-20.11M淨利潤
18.77M總股本
0.3693每股盈餘TTM
1.14Beta
5.56%ROE
4.57052週最低
7.57%振幅
69.89%毛利率
116.16M總市值
5.58回報/風險
4.09%風險率

TradingKey OptimizeRx Corp股票評分

單位: USD 更新時間: 2026-07-02

操作建議

OptimizeRx Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在軟體與IT服務行業排名93/486位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為12.40。中期看,股價處於平穩狀態。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

OptimizeRx Corp評分

相關信息

行業排名
93 / 486
全市場排名
153 / 4565
所屬行業
軟體與IT服務

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

OptimizeRx Corp亮點

亮點風險
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
業績高增長
公司營業收入穩步增長,連續3年增長53.00%
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值16.76,處於3年歷史高位
機構減倉
最新機構持股15.47M股,環比減少25.02%

分析師目標

基於 6 分析師
買入
評級
12.400
目標均價
+128.36%
漲幅空間

OptimizeRx Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

OptimizeRx Corp簡介

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
公司代碼OPRX
公司OptimizeRx Corp
CEOSilvestro (Stephen L)
網址https://www.optimizerx.com/

常見問題

OptimizeRx Corp(OPRX)的當前股價是多少?

OptimizeRx Corp(OPRX)的當前股價是 6.19。

OptimizeRx Corp 的股票代碼是什麼?

OptimizeRx Corp的股票代碼是OPRX。

OptimizeRx Corp股票的52週最高點是多少?

OptimizeRx Corp股票的52週最高點是22.25。

OptimizeRx Corp股票的52週最低點是多少?

OptimizeRx Corp股票的52週最低點是4.57。

OptimizeRx Corp的市值是多少?

OptimizeRx Corp的市值是116.16M。

現在OptimizeRx Corp(OPRX)的股票是買入、持有還是賣出?

根據分析師評級,OptimizeRx Corp(OPRX)的總體評級為買入,目標價格為12.40。

OptimizeRx Corp(OPRX)股票的每股收益(EPS TTM)是多少

OptimizeRx Corp(OPRX)股票的每股收益(EPS TTM)是0.28。